# Zemaira Eosinophilic Esophagitis Pilot Study

> **NCT05485155** · PHASE2 · RECRUITING · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 15 (estimated)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

- **DRUG:** Alpha-proteinase inhibitor

## Key facts

- **NCT ID:** NCT05485155
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-15
- **Primary completion:** 2026-10
- **Final completion:** 2027-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05485155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05485155, "Zemaira Eosinophilic Esophagitis Pilot Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05485155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*